Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: A large-scale, multiobserver prospective study on 3.0-T MRI

Academic Radiology

Volumn 20, Issue 8, 2013, Pages 939-946

  Wu, Lian Ming ^a   Chen, Xiao Xi ^a   Xu, Jian Rong ^a   Zhang, Xiao Fei ^a   Suo, Si Teng ^a   Yao, Qiu Ying ^a   Fan, Yu ^a   Hu, Jiani ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Diffusion weighted imaging; T Staging; T2 weighted imaging; Urinary Bladder Cancer

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOLOGY; HUMAN; INFORMED CONSENT; LEPROMIN TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PERFUSION WEIGHTED IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARD;

DIFFUSION-WEIGHTED IMAGING; T STAGING; T2 WEIGHTED IMAGING; URINARY BLADDER CANCER;

AGED; AGED, 80 AND OVER; CHINA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 84880036660     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2013.02.012     Document Type: Article

References (31)

1. Hadjiiski L., Chan H.P., Caoili E.M., et al. Auto-initialized cascaded level set(AI-CALS) segmentation of bladder lesions on multidetector row CT urography. Acad Radiol 2013, 20(2):148-155.
2. Josephson D., Pasin E., Stein J.P. Superficial bladder cancer. II. Management. Exp Rev Anticancer Ther 2007, 7:567-581.
3. Sherif A., Jonsson M.N., Wiklund N.P. Treatment of muscle-invasive bladder cancer. Expert Rev Anticancer Ther 2007, 7:1279-1283.
4. Knox M.K., Cowan N.C., Rivers-Bowerman M.D., et al. Evaluation of multidetector computed tomography urography and ultrasonography fordiagnosing bladder cancer. Clin Radiol 2008, 63:1317-1325.
5. Razavi S.A., Sadigh G., Kelly A.M., et al. Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy: a critically appraised topic. Acad Radiol 2012, 19(9):1134-1140.
6. Setty B.N., Holalkere N.S., Sahani D.V., et al. State-of-the-art cross-sectional imaging in bladder cancer. Curr Probl Diagn Radiol 2007, 36:83-96.
7. Baltaci S., Resorlu B., Yagci C., et al. Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urol Int 2008, 81:399-402.
8. Totaro A., Pinto F., Brescia A., et al. Imaging in bladder cancer: present role and future perspectives. Urol Int 2010, 85:373-380.
9. Husband J.E.S., Olliff J.F.C., Williams M.P., et al. Bladder cancer: staging with CT and MR imaging. Radiology 1989, 173:435-440.
10. Akmangit I., Lakadamyali H., Oto A., et al. Staging of urinary bladder tumours with CT and MRI. Turk J Diagn Intervent Radiol 2003, 9:63-69.
11. Kundra V., Siverman P.M. Imaging in oncology from the University of Texas M.D. Anderson Cancer Center. AJR Am J Roentgenol 2003, 180:1045-1054.
12. Tillou X., Grardel E., Fourmarier M., et al. Can MRI be used to distinguish between superficial and invasive transitional cell bladder cancer?. Prog Urol 2008, 18(7):440-444.
13. Barentsz J.O., Jager G.J., van Vierzen P.B., et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 1996, 201:185-193.
14. Barentsz J.O., Jager G.J., Witjes J.A., et al. Primary staging of urinary bladder carcinoma: the role of MR imaging and a comparison with CT. Eur Radiol 1996, 6:134-139.
15. Takeuchi M., Suzuki T., Sasaki S., et al. Clinicopathologic significance of high signal intensity on diffusion-weighted MR imaging in the ureter, urethra, prostate and bone of patients with bladder cancer. Acad Radiol 2012, 19(7):827-833.
16. El-Assmy A., Abou-El-Ghar M.E., Mosbah A., et al. Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 2009, 19(7):1575-1581.
17. Takeuchi M., Sasaki S., Ito M., et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009, 251(1):112-121.
18. Watanabe H., Kanematsu M., Kondo H., et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?. AJR Am J Roentgenol 2009, 192(5):1361-1366.
19. International Union Against Cancer (UICC): TNM classification of malignant tumors 1997, 170-173. Wiley-Liss, New York, NY. L.H. Sobin, C.H. Wittekind (Eds.).
20. Fisher M.R., Hricak H., Tanagho E.A. Urinary bladder MR imaging. II. Neoplasm. Radiology 1985, 157:471-477.
21. Buy J.N., Moss A.A., Guinet C., et al. MR staging of bladder carcinoma: correlation with pathologic findings. Radiology 1988, 169:695-700.
22. Rholl K.S., Lee J.K., Heiken J.P., et al. Primary bladder carcinoma: evaluation with MR imaging. Radiology 1987, 163:117-121.
23. Narumi Y., Kadota T., Inoue E., et al. Bladder wall morphology: invitro MR imaging-histopathologic correlation. Radiology 1993, 187:151-155.
24. Matsuki M., Inada Y., Tatsugami F., et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 2007, 17:201-204.
25. Zhou X., Obuchowski N., McClish D. Comparing the accuracy of two diagnostic tests. Statistical methods in diagnostic medicine 2002, 171-176. Wiley, New York, NY.
26. Park M.J., Cha E.S., Kang B.J., et al. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Kor J Radiol 2007, 8(5):390-396.
27. Baltzer P.A., Benndorf M., Dietzel M., et al. Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol 2010, 20(5):1101-1110.
28. Baltzer P.A., Renz D.M., Herrmann K.H., et al. Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol 2009, 19(7):1612-1620.
29. Tekes A., Kamel I., Imam K., et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 2005, 184:121-127.
30. Hayashi N., Tochigi H., Shiraishi T., et al. A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography. BJU Int 2000, 85:32-36.
31. Narumi Y., Kadota T., Inoue E., et al. Bladder tumors: staging withgadolinium-enhanced oblique MR imaging. Radiology 1993, 187:145-150.